Literature DB >> 9844052

Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection.

A Kalinkovich1, Z Weisman, Z Greenberg, J Nahmias, S Eitan, M Stein, Z Bentwich.   

Abstract

We have previously reported the presence of marked immune dysregulation with a dominant Th2 profile, in a population of Ethiopian immigrants (ETH) in Israel heavily infected with helminths. In order to characterize better this immune dysregulation we studied by flow cytometry the expression of several activation markers on peripheral T cell populations, and lymphocyte apoptosis, in blood samples obtained from 63 'new' ETH (recently arrived), 18 'old' ETH (> 5 years since immigration) and 34 non-Ethiopian Israelis. The main findings in the 'new' ETH group in comparison with the non-Ethiopian controls were: (i) decreased CD4 and increased CD8 lymphocyte counts; (ii) elevated levels of activated T cells (CD3, CD4 and CD8) expressing HLA-DR; (iii) decreased levels of 'naive' CD4+ cells (CD45RA+), with increased levels of 'memory' CD4+ cells (CD45RO+); (iv) decreased numbers of CD28+ CD8+ lymphocytes; (v) marked increase in lymphocyte apoptosis. These T cell alterations and activation profile remained unchanged in 10 'new' ETH in whom the helminth infections persisted for 6-11 months. In contrast, in 18 'old' ETH, without helminth infections, the T cell activation profile was within the normal range. These findings suggest that chronic helminth infections may have a profound effect on the immune system of the host that disappears after eradication of these infections and adjustment to the new environment. It should therefore be taken into consideration for every immunomodulation therapy and especially in vaccine design and trials, in regions endemic for helminth infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844052      PMCID: PMC1905129          DOI: 10.1046/j.1365-2249.1998.00736.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  56 in total

1.  Factors that influence activated CD8+ T-cell apoptosis in patients with acute herpesvirus infections: loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression.

Authors:  N J Borthwick; M Bofill; I Hassan; P Panayiotidis; G Janossy; M Salmon; A N Akbar
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

2.  CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection.

Authors:  S Zanussi; C Simonelli; M D'Andrea; C Caffau; M Clerici; U Tirelli; P DePaoli
Journal:  Clin Exp Immunol       Date:  1996-08       Impact factor: 4.330

3.  Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis.

Authors:  H Kaneko; K Saito; H Hashimoto; H Yagita; K Okumura; M Azuma
Journal:  Clin Exp Immunol       Date:  1996-11       Impact factor: 4.330

4.  Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals.

Authors:  G Rizzardini; S Piconi; S Ruzzante; M L Fusi; M Lukwiya; S Declich; M Tamburini; M L Villa; M Fabiani; F Milazzo; M Clerici
Journal:  AIDS       Date:  1996-11       Impact factor: 4.177

5.  Evidence of a T helper type 2 activation in human schistosomiasis.

Authors:  M I Araújo; A R de Jesus; O Bacellar; E Sabin; E Pearce; E M Carvalho
Journal:  Eur J Immunol       Date:  1996-06       Impact factor: 5.532

6.  Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.

Authors:  E A Sabin; M I Araujo; E M Carvalho; E J Pearce
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

7.  Chagasic patients lack CD28 expression on many of their circulating T lymphocytes.

Authors:  W O Dutra; O A Martins-Filho; J R Cançado; J C Pinto-Dias; Z Brener; G Gazzinelli; J F Carvalho; D G Colley
Journal:  Scand J Immunol       Date:  1996-01       Impact factor: 3.487

8.  Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections?

Authors:  Z Bentwich; Z Weisman; C Moroz; S Bar-Yehuda; A Kalinkovich
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

9.  The enigma of CD57+CD28- T cell expansion--anergy or activation?

Authors:  F Kern; S Ode-Hakim; K Vogt; C Hoflich; P Reinke; H D Volk
Journal:  Clin Exp Immunol       Date:  1996-04       Impact factor: 4.330

10.  Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1.

Authors:  D M Thea; R Porat; K Nagimbi; M Baangi; M E St Louis; G Kaplan; C A Dinarello; G T Keusch
Journal:  Ann Intern Med       Date:  1996-04-15       Impact factor: 25.391

View more
  42 in total

1.  Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales.

Authors:  A Kassu; A Tsegaye; B Petros; D Wolday; E Hailu; T Tilahun; B Hailu; M T Roos; A L Fontanet; D Hamann; T F De Wit
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  West African donors have high percentages of activated cytokine producing T cells that are prone to apoptosis.

Authors:  K Kemp; B D Akanmori; L Hviid
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 3.  Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

4.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

5.  Role for nitric oxide in hookworm-associated immune suppression.

Authors:  Blaise Dondji; Richard D Bungiro; Lisa M Harrison; Jon J Vermeire; Carlo Bifulco; Diane McMahon-Pratt; Michael Cappello
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

6.  Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.

Authors:  T Resende Co; C S Hirsch; Z Toossi; R Dietze; R Ribeiro-Rodrigues
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 7.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Parasitic disease screening among HIV patients from endemic countries in a Toronto clinic.

Authors:  Cecilia T Costiniuk; Curtis L Cooper; Steve Doucette; Colin M Kovacs
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

9.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.

Authors:  Judd L Walson; Phelgona A Otieno; Margaret Mbuchi; Barbra A Richardson; Barbara Lohman-Payne; Steve Wanyee Macharia; Julie Overbaugh; James Berkley; Eduard J Sanders; Michael H Chung; Grace C John-Stewart
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

10.  Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.

Authors:  Rbl Zinyama-Gutsire; E Gomo; P Kallestrup; C Erikstrup; H Ullum; A E Butterworth; S Munyati; T Mduluza
Journal:  BMC Infect Dis       Date:  2009-10-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.